We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Comment & Response |

Trypan Blue Vital Dye Staining vs TUNEL Technique to Detect Corneal Endothelium Toxic Effects—Reply

Noelle L. Pruzan, MD1; Jeremy D. Keenan, MD, MPH1,2; Bennie H. Jeng, MD, MS1,2,3,4
[+] Author Affiliations
1Department of Ophthalmology, University of California, San Francisco
2Francis I. Proctor Foundation, University of California, San Francisco
3Department of Ophthalmology, San Francisco General Hospital, San Francisco, California
4Department of Ophthalmology and Visual Sciences, University of Maryland School of Medicine, Baltimore
JAMA Ophthalmol. 2014;132(12):1491. doi:10.1001/jamaophthalmol.2014.3614.
Text Size: A A A
Published online


In Reply There is no gold standard or widely accepted staining protocol for assessing endothelial cell death in human corneas after storage. We followed the vital dye staining protocol proposed by Park et al,1 who validated the ability of trypan blue to detect endothelial damage by comparing corneas exposed to hydrogen peroxide with those exposed to balanced salt solution and found that the optimal dye concentration was 0.4%. The only other study, to our knowledge, of an antifungal additive in Optisol-GS also used the trypan blue technique to evaluate corneal endothelial toxic effects.2


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





December 1, 2014
Sertan Goktas, MD; Yasar Sakarya, MD; Rabia Sakarya, MD
1Department of Ophthalmology, Konya Training and Research Hospital, Konya, Turkey
JAMA Ophthalmol. 2014;132(12):1491. doi:10.1001/jamaophthalmol.2014.3360.
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...